Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure

J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07437-1. doi: 10.1016/j.jacc.2026.08.013. Online ahead of print.ABSTRACTBACKGROUND: The World Health Organization (WHO) defines anemia as hemoglobin concentration <12 g/dL in women and <13 g/dL in men. Although widely used clinically, these thresholds wer

M Misato Chimura

Eplontersen for Transthyretin Amyloid Cardiomyopathy

N Engl J Med. 2026 Aug 28. doi: 10.1056/NEJMoa2608510. Online ahead of print.ABSTRACTBACKGROUND: Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease caused by deposition of misfolded transthyretin (TTR). Eplontersen, an antisense oligonucleotide, reduce

M Marianna Fontana

Research progress on BTG2 in non‑tumor diseases (Review)

Int J Mol Med. 2026 Nov;58(5):299. doi: 10.3892/ijmm.2026.5970. Epub 2026 Aug 28.ABSTRACTThe B‑cell translocation gene 2 (BTG2), originally identified as a tumor suppressor, has been extensively studied in oncology research. However, its multifaceted functions in non‑tumor diseases are still being r

S Shuling Li

Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society

Eur J Heart Fail. 2026 Aug 28:xuag271. doi: 10.1093/ejhf/xuag271. Online ahead of print.ABSTRACTMyocarditis is an important and frequently underrecognized cause of atrioventricular conduction disease and ventricular arrhythmias and may also be associated with atrial arrhythmias and sinus node dysfun

G Giovanni Peretto